ARTICLE | Clinical News

Toctino alitretinoin regulatory update

December 13, 2010 8:00 AM UTC

Basilea said its Toctino alitretinoin was recommended in the updated Canadian Hand Dermatitis Management Guidelines as the systemic treatment of choice for severe chronic hand eczema unresponsive to potent topical corticosteroids. The guidelines were published in the Journal of Cutaneous Medicine and Surgery. ...